NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00264-1800-31 — Sodium chloride 0.9% IV solutionAI (516 hospitals, 4,837,230–4,850,865 samples)
• NDC 00338-0049-10 — Sodium chloride 0.9% IV solutionAI (261 hospitals, 4,777,886–4,789,388 samples)
• NDC 00338-0049-03 — Sodium chloride 0.9% IV solutionAI (928 hospitals, 4,607,545–4,627,624 samples)
• NDC 00409-3178-03 — Lidocaine with epinephrine injection solutionAI (524 hospitals, 4,572,804–4,575,657 samples)
• NDC 00338-0049-11 — Intravenous 0.9% saline solutionAI (470 hospitals, 4,292,384–4,307,540 samples)
• NDC 76297-0001-31 — Sodium chloride 0.9% saline solution, 250 mL bagAI (160 hospitals, 4,181,753–4,182,086 samples)
• NDC 00338-0049-48 — Sodium chloride 0.9% IV solutionAI (644 hospitals, 4,071,902–4,090,379 samples)
• NDC 55150-0169-10 — Bupivacaine 0.5% injection (preservative-free) for local numbingAI (836 hospitals, 4,067,757–4,075,668 samples)
• NDC 00409-4279-02 — Lidocaine 1% injection solutionAI (664 hospitals, 3,630,092–3,639,281 samples)
• NDC 00517-2340-10 — Iron sucrose injectionAI (1046 hospitals, 3,631,401–3,634,299 samples)
• NDC 65597-0406-01 — Trastuzumab deruxtecan 100 mg vialAI (982 hospitals, 3,585,263–3,586,091 samples)
• NDC 00990-7984-20 — Saline 0.9% intravenous fluid bolusAI (223 hospitals, 3,341,316–3,347,589 samples)
• NDC 00338-0049-41 — Sodium chloride 0.9% IV solutionAI (633 hospitals, 3,144,866–3,162,659 samples)
• NDC 63323-0269-37 — Propofol intravenous emulsion 200 mg per 20 mLAI (380 hospitals, 3,045,519–3,046,707 samples)
• NDC 16714-0528-10 — Propofol injection, 10 mg/mL, 20 mL vialAI (89 hospitals, 2,948,806–2,949,103 samples)
• NDC 00990-7984-13 — Sodium chloride 0.9% IV solutionAI (239 hospitals, 2,909,629–2,910,115 samples)
• NDC 00264-1800-32 — Sodium chloride 0.9% IV solutionAI (640 hospitals, 2,880,088–2,893,741 samples)
• NDC 00310-4611-50 — Imfinzi (durvalumab) 500 mg IV injection vialAI (839 hospitals, 2,730,927–2,731,944 samples)
• NDC 00338-0089-04 — Dextrose and saline IV fluidAI (868 hospitals, 2,708,249–2,710,967 samples)
• NDC 65757-0300-01 — Naltrexone extended-release injection 380 mg kitAI (576 hospitals, 2,599,545–2,599,887 samples)
• NDC 00006-3026-02 — Keytruda 100 mg/4 mL intravenous solutionAI (797 hospitals, 2,597,991–2,599,206 samples)
• NDC 00338-0803-04 — Potassium chloride in dextrose and saline IV solutionAI (801 hospitals, 2,589,081–2,591,115 samples)
• NDC 00338-0049-31 — Sodium chloride 0.9% IV solutionAI (364 hospitals, 2,250,322–2,264,191 samples)
• NDC 61314-0326-01 — Zarxio 480 mcg/0.8 mL injection syringeAI (959 hospitals, 2,216,104–2,216,869 samples)
• NDC 00990-7983-55 — Sodium chloride 0.9% intravenous solutionAI (187 hospitals, 2,214,064–2,216,296 samples)
• NDC 76297-0001-22 — Sodium chloride 0.9% IV solutionAI (103 hospitals, 2,201,162–2,207,507 samples)
• NDC 00338-9791-01 — Sodium chloride 0.9% IV bolus for neonatesAI (196 hospitals, 2,183,287–2,184,187 samples)
• NDC 99999-0109-38 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION IP (1 hospital, 2,004,467 samples)
• NDC 68817-0134-50 — Paclitaxel protein-bound 100 mg vialAI (964 hospitals, 1,924,121–1,924,976 samples)
• NDC 00338-0671-04 — Potassium chloride in dextrose and saline IV solutionAI (845 hospitals, 1,876,027–1,877,953 samples)
• NDC 64253-0333-35 — Heparin lock flush solution 100 units per mLAI (854 hospitals, 1,850,539–1,861,357 samples)
• NDC 68135-0811-02 — Cerliponase alfa injection into the brain's ventriclesAI (69 hospitals, 1,620,205–1,620,232 samples)
• NDC 50242-0070-01 — Gazyva (obinutuzumab) 1000 mg IV infusionAI (1110 hospitals, 1,612,178–1,612,682 samples)
• NDC 00548-5400-00 — Medroxyprogesterone acetate 150 mg/mL injectionAI (486 hospitals, 1,490,795–1,491,182 samples)
• NDC 50242-0922-01 — Emicizumab injection, 105 mg vialAI (183 hospitals, 1,487,343 samples)
• NDC 55150-0155-20 — Acyclovir sodium intravenous solution, 50 mg/mLAI (717 hospitals, 1,345,686–1,345,929 samples)
• NDC 00270-1316-30 — Iopamidol 76% IV contrast injectionAI (353 hospitals, 1,315,480–1,320,151 samples)
• NDC 63323-0482-57 — Lidocaine with epinephrine injectionAI (657 hospitals, 1,282,718–1,289,819 samples)
• NDC 00409-3178-02 — Lidocaine with epinephrine injectionAI (650 hospitals, 1,258,510–1,264,279 samples)
• NDC 00409-0007-10 — Lidocaine with epinephrine injectionAI (364 hospitals, 1,257,755–1,261,157 samples)
• NDC 00186-0150-99 — LIDOCAINE-EPINEPHRINE 1 %-1:100000 IJ SOLN (2 hospitals, 1,250,055 samples)
• NDC 00990-7953-03 — lactated Ringers intravenous solutionAI (247 hospitals, 1,189,329–1,190,148 samples)
• NDC 00944-0495-05 — Flexbumin 5% intravenous albumin solutionAI (642 hospitals, 1,187,875–1,189,144 samples)
• NDC 00338-0705-48 — Potassium chloride IV solutionAI (845 hospitals, 1,165,365–1,167,921 samples)
• NDC 00338-0049-38 — Sodium chloride 0.9% IV solutionAI (480 hospitals, 1,091,946–1,107,822 samples)
• NDC 44206-0251-10 — Human albumin 25% IV solutionAI (707 hospitals, 1,079,830–1,082,782 samples)
• NDC 00069-0249-01 — Ruxience 500 mg/50 mL IV solutionAI (937 hospitals, 1,029,608–1,030,193 samples)
• NDC 00338-0089-03 — Dextrose and saline intravenous fluidAI (361 hospitals, 1,001,581–1,003,219 samples)
• NDC 55150-0247-47 — Levetiracetam IV solution 1000 mg in 100 mLAI (357 hospitals, 1,001,643–1,002,390 samples)
• NDC 08888-0018-76 — NACL 0.9% IV SOLP (1 hospital, 972,599 samples)